Petros Pharmaceuticals Statistics
Total Valuation
PTPI has a market cap or net worth of $2.95 million. The enterprise value is $6.39 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024, after market close.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PTPI has 10.01 million shares outstanding. The number of shares has increased by 190.11% in one year.
| Current Share Class | 10.01M |
| Shares Outstanding | 10.01M |
| Shares Change (YoY) | +190.11% |
| Shares Change (QoQ) | +33.05% |
| Owned by Insiders (%) | 0.36% |
| Owned by Institutions (%) | 1.79% |
| Float | 9.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.45 |
| Forward PS | 2.25 |
| PB Ratio | 0.95 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 2.35.
| Current Ratio | 0.85 |
| Quick Ratio | 0.47 |
| Debt / Equity | 2.35 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -26.17 |
Financial Efficiency
Return on equity (ROE) is -92.93% and return on invested capital (ROIC) is -64.82%.
| Return on Equity (ROE) | -92.93% |
| Return on Assets (ROA) | -28.49% |
| Return on Capital (ROIC) | -64.82% |
| Revenue Per Employee | $191,542 |
| Profits Per Employee | -$945,170 |
| Employee Count | 21 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 0.40 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.00% in the last 52 weeks. The beta is 2.13, so PTPI's price volatility has been higher than the market average.
| Beta (5Y) | 2.13 |
| 52-Week Price Change | -77.00% |
| 50-Day Moving Average | 0.32 |
| 200-Day Moving Average | 0.53 |
| Relative Strength Index (RSI) | 46.90 |
| Average Volume (20 Days) | 4,450,387 |
Short Selling Information
The latest short interest is 181,045, so 1.81% of the outstanding shares have been sold short.
| Short Interest | 181,045 |
| Short Previous Month | 200,562 |
| Short % of Shares Out | 1.81% |
| Short % of Float | 1.92% |
| Short Ratio (days to cover) | 0.72 |
Income Statement
In the last 12 months, PTPI had revenue of $4.02 million and -$19.85 million in losses. Loss per share was -$3.26.
| Revenue | 4.02M |
| Gross Profit | 2.92M |
| Operating Income | -13.59M |
| Pretax Income | -8.94M |
| Net Income | -19.85M |
| EBITDA | -10.61M |
| EBIT | -13.59M |
| Loss Per Share | -$3.26 |
Full Income StatementBalance Sheet
The company has $3.89 million in cash and $7.34 million in debt, giving a net cash position of -$3.45 million or -$0.34 per share.
| Cash & Cash Equivalents | 3.89M |
| Total Debt | 7.34M |
| Net Cash | -3.45M |
| Net Cash Per Share | -$0.34 |
| Equity (Book Value) | 3.12M |
| Book Value Per Share | 0.31 |
| Working Capital | -1.84M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.83 million and capital expenditures -$19,138, giving a free cash flow of -$5.85 million.
| Operating Cash Flow | -5.83M |
| Capital Expenditures | -19,138 |
| Free Cash Flow | -5.85M |
| FCF Per Share | -$0.58 |
Full Cash Flow StatementMargins
Gross margin is 72.50%, with operating and profit margins of -337.80% and -117.52%.
| Gross Margin | 72.50% |
| Operating Margin | -337.80% |
| Pretax Margin | -117.52% |
| Profit Margin | -117.52% |
| EBITDA Margin | -263.77% |
| EBIT Margin | n/a |
| FCF Margin | n/a |